KASID
Search
- Page Path
- HOME > Search
Case Report
- Miscellaneous
- Endoscopic balloon dilations for strictures of rectum, ileocecal valve and duodenum in a patient with X-linked inhibitor of apoptosis deficiency: a case report
- Shinsuke Otagiri, Takehiko Katsurada, Kensuke Sakurai, Junichi Sugita, Naoya Sakamoto
- Intest Res 2022;20(2):274-277. Published online February 8, 2022
- DOI: https://doi.org/10.5217/ir.2021.00029
-
Abstract
PDF
PubReader
ePub - X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency and gastrointestinal (GI) lesions in XIAP deficiency are similar to Crohn’s disease. For patients with Crohn’s disease, endoscopic balloon dilation (EBD) is known to be a standard procedure for intestinal strictures including upper GI tract. However, there are no articles which mention the efficacy of EBDs for the strictures in upper GI tract in patients with XIAP deficiency. Herein, we describe an 18-year-old male with XIAP deficiency in whom EBDs for the rectum, ileocecal valve (ICV), and duodenum were performed. Before hematopoietic stem cell transplantation (HSCT), GI endoscopy revealed strictures of the rectum, ICV and duodenum with active ulcers. Although these ulcers healed after HSCT, the strictures progressed. Therefore, we performed EBDs for the strictures of the rectum, ICV, and duodenum. In contrast studies, we did not find any other strictures in the small intestine. Throughout the patient’s clinical course, no complications of EBD occurred. He started eating after EBDs, but abdominal symptoms did not relapse without any dietary restrictions. Our case suggests that EBD could be an effective and safe procedure for intestinal strictures including upper GI tract after HSCT in patients with XIAP deficiency.
- 5,235 View
- 273 Download
Original Articles
- Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells
- Yu Chuan Liu, Se Lim Kim, Young Ran Park, Soo-Teik Lee, Sang Wook Kim
- Intest Res 2017;15(2):174-181. Published online April 27, 2017
- DOI: https://doi.org/10.5217/ir.2017.15.2.174
-
Abstract
PDFPubReaderePub
<b>Background/Aims</b><br/> Parthenolide (PT), a principle component derived from feverfew (
Tanacetum parthenium ), is a promising anticancer agent and has been shown to promote apoptotic cell death in various cancer cells. In this study, we focused on its functional role in apoptosis, migration, and invasion of human colorectal cancer (CRC) cells.Methods SW620 cells were employed as representative human CRC cells. We performed the MTT assay and cell cycle analysis to measure apoptotic cell death. The wound healing, Transwell migration, and Matrigel invasion assays were performed to investigate the effect of PT on cell migration/invasion. Western blotting was used to establish the signaling pathway of apoptosis and cell migration/invasion.
Results PT exerts antiproliferative effect and induces apoptotic cell death of SW620 cells. In addition, PT prevents cell migration and invasion in a dose-dependent manner. Moreover, PT markedly suppressed migration/invasion-related protein expression, including E-cadherin, β-catenin, vimentin, Snail, cyclooxygenase-2, matrix metalloproteinase-2 (MMP-2), and MMP-9 in SW620 cells. PT also inhibited the expression of antiapoptotic proteins (Bcl-2 and Bcl-xL) and activated apoptosis terminal factor (caspase-3) in a dose-dependent manner.
Conclusions Our results suggest that PT is a potential novel therapeutic agent for aggressive CRC treatment.
-
Citations
Citations to this article as recorded by
- Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer
Fatemeh Mehdikhani, Homa Hajimehdipoor, Mojgan Tansaz, Marc Maresca, Sadegh Rajabi
Biomolecules.2025; 15(2): 268. CrossRef - Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide
Jian Li, Xin Li, Hongwei Liu
Frontiers in Pharmacology.2025;[Epub] CrossRef - Cyanidin-3-O-glucoside inhibits the malignant progression of colorectal cancer by regulating Kruppel-like factor 4-mediated ERK/p38 signaling pathway
Jian Chang, Geqiong Xiao
Toxicology and Applied Pharmacology.2025; 497: 117268. CrossRef - Novel formulation of parthenolide-loaded liposome coated with chitosan and evaluation of its potential anticancer effects in vitro
Parisa Karimian Ensaf, Mohammad Taghi Goodarzi, Masoud Homayouni Tabrizi, Ali Neamati, Samira Sadat Hosseinyzadeh
Molecular Biology Reports.2024;[Epub] CrossRef - Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis
Chou-Yi Hsu, Sadegh Rajabi, Maryam Hamzeloo-Moghadam, Abhinav Kumar, Marc Maresca, Pallavi Ghildiyal
Frontiers in Pharmacology.2024;[Epub] CrossRef - Exploring the Phytochemistry, Signaling Pathways, and Mechanisms of Action of Tanacetum parthenium (L.) Sch.Bip.: A Comprehensive Literature Review
Ali Kashkooe, Atefeh Jalali, Mohammad M. Zarshenas, Azadeh Hamedi
Biomedicines.2024; 12(10): 2297. CrossRef - Bitter taste signaling in cancer
Ana R. Costa, Ana C. Duarte, Ana R. Costa-Brito, Isabel Gonçalves, Cecília R.A. Santos
Life Sciences.2023; 315: 121363. CrossRef - Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells
Adriana S. Gehren, Waldemir F. de Souza, Annie C. M. Sousa‐Squiavinato, Diego A. A. Ramos, Bruno R. B. Pires, Eliana S. F. W. Abdelhay, Jose A. Morgado‐Diaz
Cell Biology International.2023; 47(9): 1638. CrossRef - Novel shikonin derivative suppresses tumor growth and metastasis intervention of Wnt/β-catenin pathway
Hongwei Han, Zhongling Wen, Xiaohui Lai, Minkai Yang, Jiangyan Fu, Liangjie Yang, Qingqing Chen, Yudi Ma, Wencai Jie, Changyi Wang, Tongming Yin, Guihua Lu, Xiaoming Wang, Shucun Sun, Quan Zhao, Jinliang Qi, Hongyan Lin, Yonghua Yang
Process Biochemistry.2023; 132: 297. CrossRef - Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition
Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, Nisreen E. Elwany
Life Sciences.2023; 331: 122037. CrossRef - TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer
Sumeet Singh, Vinita Gouri, Mukesh Samant
Medical Oncology.2023;[Epub] CrossRef - Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers
Beste Turanli
OMICS: A Journal of Integrative Biology.2023; 27(10): 483. CrossRef - Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
Daniela Carlisi, Marianna Lauricella, Antonella D’Anneo, Anna De Blasio, Adriana Celesia, Giovanni Pratelli, Antonietta Notaro, Giuseppe Calvaruso, Michela Giuliano, Sonia Emanuele
Biomedicines.2022; 10(2): 514. CrossRef - Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies
Hazera Binte Sufian, Julianna Maria Santos, Zeina S. Khan, Sobia Ahsan Halim, Ajmal Khan, Maliha Tabassum Munir, MD Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman
Life Sciences.2022; 301: 120610. CrossRef - Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide
Yubo Dong, Xuanjin Qian, Jian Li, Ahmed Faeq Hussein
Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef - Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents
Xingchen LIU, Xiaobing WANG
Chinese Journal of Natural Medicines.2022; 20(11): 814. CrossRef - Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
Cancers.2021; 13(8): 1786. CrossRef - Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
Magdalena Rausch, Adriano Rutz, Pierre-Marie Allard, Céline Delucinge-Vivier, Mylène Docquier, Olivier Dormond, Paul J. Dyson, Jean-Luc Wolfender, Patrycja Nowak-Sliwinska
Cancers.2021; 13(16): 3978. CrossRef - 6 α-Hydroxy-4[14], 10[15]-guainadien-8β, 12-olide induced cell cycle arrest via modulation of EMT and Wnt/β-catenin pathway in HER-2 positive breast cancer cells
Gitanjali Javir, Kalpana Joshi, Vijay Khedkar, Supada Rojatkar
The Journal of Steroid Biochemistry and Molecular Biology.2020; 197: 105514. CrossRef - Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth
Xue Li, Lingmei Kong, Qihong Yang, Aizhu Duan, Xiaoman Ju, Bicheng Cai, Lin Chen, Tao An, Yan Li
Journal of Biological Chemistry.2020; 295(11): 3576. CrossRef - Metabonomic study of the intervention effects of Parthenolide on anti-thyroid cancer activity
Lili Yuan, Zhe Wang, Dongyang Zhang, Jiahe Wang
Journal of Chromatography B.2020; 1150: 122179. CrossRef - ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
Xiao‐Han Jin, Yong‐Sheng Jia, Ye‐Hui Shi, Qiu‐Ying Li, Shi‐Qi Bao, Wen‐Ping Lu, Zhong‐Sheng Tong
Journal of Cellular Biochemistry.2019; 120(2): 1386. CrossRef - Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
Mona Dawood, Edna Ooko, Thomas Efferth
Frontiers in Pharmacology.2019;[Epub] CrossRef - Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
Shi Mao Zhu, Yong Ran Park, Seung Yong Seo, In Hee Kim, Soo Teik Lee, Sang Wook Kim
Intestinal Research.2019; 17(4): 527. CrossRef - Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
Luksana Chaiswing, William H. St. Clair, Daret K. St. Clair
Antioxidants & Redox Signaling.2018; 29(13): 1237. CrossRef - Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression
Wamidh H. Talib, Lina T. Al Kury
Biomedicine & Pharmacotherapy.2018; 107: 1488. CrossRef - Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer
Sen Jiang, Kun Zhang, Yan He, Xuetao Xu, Dongli Li, Shupeng Cheng, Xi Zheng
RSC Advances.2018; 8(5): 2768. CrossRef - The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis
Xin Jin, Jianping Zhou, Zhenhai Zhang, Huixia Lv
Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup3): 931. CrossRef
- Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer
- 7,699 View
- 97 Download
- 32 Web of Science
- 28 Crossref
- Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
- Hyun-Young Kim, Se-Lim Kim, Young-Ran Park, Yu-Chuan Liu, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
- Intest Res 2015;13(3):233-241. Published online June 9, 2015
- DOI: https://doi.org/10.5217/ir.2015.13.3.233
-
Abstract
PDFPubReader
<b>Background/Aims</b><br/> Balsalazide is an anti-inflammatory drug used in the treatment of inflammatory bowel disease. Balsalazide can reduce inflammatory responses via several mechanisms, including inhibition of nuclear factor-κB (NF-κB) activity. Parthenolide (PT) inhibits NF-κB and exerts promising anticancer effects by promoting apoptosis. The present investigated the antitumor effects of balsalazide, combined with PT, on NF-κB in a representative human colorectal carcinoma cell line, HCT116.
Methods We counted cells and conducted annexin-V assays and cell cycle analysis to measure apoptotic cell death. Western blotting was used investigate the levels of proteins involved in apoptosis.
Results PT and balsalazide produced synergistic anti-proliferative effects and induced apoptotic cell death. The combination of balsalazide and PT markedly suppressed nuclear translocation of the NF-κB p65 subunit and the phosphorylation of inhibitor of NF-κB. Moreover, PT and balsalazide dramatically enhanced NF-κB p65 phosphorylation. Apoptosis, through the mitochondrial pathway, was confirmed by detecting effects on Bcl-2 family members, cytochrome c release, and activation of caspase-3 and -8.
Conclusions Combination treatment with PT and balsalazide may offer an effective strategy for the induction of apoptosis in HCT116 cells.
-
Citations
Citations to this article as recorded by- Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
Cancers.2021; 13(8): 1786. CrossRef - Computational investigation of FDA approved drugs as selective PARP-1 inhibitors by targeting BRCT domain for cancer therapy
Chandan Kumar, P.T.V. Lakshmi, Annamalai Arunachalam
Journal of Molecular Graphics and Modelling.2021; 108: 107919. CrossRef - Identification of Autophagy-Associated Biomarkers and Corresponding Regulatory Factors in the Progression of Colorectal Cancer
Chunrui Zhang, Jing Jiang, Liqiang Wang, Liyu Zheng, Jiankai Xu, Xiaolin Qi, Huiying Huang, Jianping Lu, Kongning Li, Hong Wang
Frontiers in Genetics.2020;[Epub] CrossRef - Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells
Arash Ghorbani-Abdi-Saedabad, Mohammad Yahya Hanafi-Bojd, Negin Parsamanesh, Zahra Tayarani-Najaran, Homa Mollaei, Reyhane Hoshyar
Molecular Biology Reports.2020; 47(8): 5807. CrossRef - Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
Malgorzata Sztiller-Sikorska, Malgorzata Czyz
Pharmaceuticals.2020; 13(8): 194. CrossRef - Integration of genetic variants and gene network for drug repurposing in colorectal cancer
Lalu Muhammad Irham, Henry Sung-Ching Wong, Wan-Hsuan Chou, Wirawan Adikusuma, Eko Mugiyanto, Wan-Chen Huang, Wei-Chiao Chang
Pharmacological Research.2020; 161: 105203. CrossRef - Synthesis of azo dyes possessing N-heterocycles and evaluation of their anticancer and antibacterial properties
Zarrin Ghasemi, Sajjad Azizi, Roya Salehi, Hossein Samadi Kafil
Monatshefte für Chemie - Chemical Monthly.2018; 149(1): 149. CrossRef - Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway
Xiao-he Li, Ting Xiao, Jia-huan Yang, Yuan Qin, Jing-jing Gao, Hui-juan Liu, Hong-gang Zhou
Respiratory Research.2018;[Epub] CrossRef - Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth
Eun-Kyung Kim, Jae Hee Cho, EuiJoo Kim, Yoon Jae Kim, Aamir Ahmad
PLOS ONE.2017; 12(7): e0181183. CrossRef - Dietary selenium protects adiponectin knockout mice against chronic inflammation induced colon cancer
Arpit Saxena, Raja Fayad, Kamaljeet Kaur, Samantha Truman, Julian Greer, James A. Carson, Anindya Chanda
Cancer Biology & Therapy.2017; 18(4): 257. CrossRef - Sesquiterpene binding Gly-Leu-Ser/Lys-“co-adaptation pocket” to inhibit lung cancer cell epithelial-mesenchymal transition
Xiao-Yu Ai, Heng Zhang, Shao-Yan Gao, Yuan Qin, Wei-Long Zhong, Ju Gu, Meng Li, Kai-Liang Qiao, Qin Tian, Zhan-Hong Cui, Jia-Huan Yang, Zhun Bi, Ting Xiao, Shuang Chen, Hui-Juan Liu, Hong-Gang Zhou, Tao Sun, Cheng Yang
Oncotarget.2017; 8(41): 70192. CrossRef - Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction
Liang Chen, Ya-Qiong Xiong, Jing Xu, Ji-Peng Wang, Zi-Li Meng, Yong-Qing Hong
Oncotarget.2017; 8(55): 93878. CrossRef - Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT/NF-κB signaling pathway
Xianjin Zhu, Yanfang Song, Conglian Wu, Chuxi Pan, Pingxia Lu, Meihua Wang, Peizheng Zheng, Rongfen Huo, Chenqing Zhang, Wanting Li, Yulin Lin, Yingping Cao, Ningli Li
Scientific Reports.2016;[Epub] CrossRef
- Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
- 6,185 View
- 44 Download
- 14 Web of Science
- 13 Crossref
- Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway
- Kieu Thi Thu Trang, Se-Lim Kim, Sang-Bae Park, Seung-Young Seo, Chung-Hwan Choi, Jin-Kyoung Park, Jin-Chang Moon, Soo-Teik Lee, Sang-Wook Kim
- Intest Res 2014;12(1):34-41. Published online January 28, 2014
- DOI: https://doi.org/10.5217/ir.2014.12.1.34
-
Abstract
PDFPubReader
<b>Background/Aims</b><br/> Combination therapy utilizing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in conjunction with other anticancer agents, is a promising strategy to overcome TRAIL resistance in malignant cells. Recently, parthenolide (PT) has proved to be a promising anticancer agent, and several studies have explored its use in combination therapy. Here, we investigated the molecular mechanisms by which PT sensitizes colorectal cancer (CRC) cells to TRAIL-induced apoptosis.
Methods HT-29 cells (TRAIL-resistant) were treated with PT and/or TRAIL for 24 hours. The inhibitory effect on proliferation was detected using the 3-(4, 5-dimethylthiazol-2yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Annexin V staining, cell cycle analysis, and Hoechst 33258 staining were used to assess apoptotic cell death. Activation of an apoptotic pathway was confirmed by Western blot.
Results Treatment with TRAIL alone inhibited the proliferation of HCT 116 cells in a dose-dependent manner, whereas proliferation was not affected in HT-29 cells. Combination PT and TRAIL treatment significantly inhibited cell growth and induced apoptosis of HT-29 cells. We observed that the synergistic effect was associated with misregulation of B-cell lymphoma 2 (Bcl-2) family members, release of cytochrome C to the cytosol, activation of caspases, and increased levels of p53.
Conclusion Combination therapy using PT and TRAIL might offer an effetive strategy to overcome TRAIL resistance in certain CRC cells.
-
Citations
Citations to this article as recorded by- Nanomagnetic Liposome-Encapsulated Parthenolide and Indocyanine Green for Targeting and Chemo-Photothermal Antitumor Therapy
Wenbin Gao, Lei Li, Xuwu Zhang, Liyao Luo, Yuchu He, Cong Cong, Dawei Gao
Nanomedicine.2020; 15(9): 871. CrossRef - Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy
Wenbin Gao, Shipan Wei, Zhuo Li, Lei Li, Xuwu Zhang, Chunhui Li, Dawei Gao
Nanotechnology.2020; 31(35): 355104. CrossRef - Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells
Arash Ghorbani-Abdi-Saedabad, Mohammad Yahya Hanafi-Bojd, Negin Parsamanesh, Zahra Tayarani-Najaran, Homa Mollaei, Reyhane Hoshyar
Molecular Biology Reports.2020; 47(8): 5807. CrossRef - Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
Malgorzata Sztiller-Sikorska, Malgorzata Czyz
Pharmaceuticals.2020; 13(8): 194. CrossRef - Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
Ali Hassanzadeh, Majid Farshdousti Hagh, Mohammad Reza Alivand, Ali Akbar Movassaghpour Akbari, Karim Shams Asenjan, Raedeh Saraei, Saeed Solali
Journal of Cellular Physiology.2018; 233(10): 6470. CrossRef - Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species
Gabriela Flores‐Lopez, Dafne Moreno‐Lorenzana, Manuel Ayala‐Sanchez, Socrates Aviles‐Vazquez, Hector Torres‐Martinez, Peter A. Crooks, Monica L. Guzman, Hector Mayani, Antonieta Chávez‐González
Journal of Cellular and Molecular Medicine.2018; 22(10): 4899. CrossRef - Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation
Se-Lim Kim, Seong Hun Kim, Young Ran Park, Yu-Chuan Liu, Eun-Mi Kim, Hwan-Jeong Jeong, Yo Na Kim, Seung Young Seo, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang-Wook Kim
Molecular Cancer Research.2017; 15(2): 141. CrossRef - Protective effects of Alpha-lipoic acid on MeHg-induced oxidative damage and intracellular Ca2+dyshomeostasis in primary cultured neurons
Tianyao Yang, Zhaofa Xu, Wei Liu, Bin Xu, Yu Deng
Free Radical Research.2016; 50(5): 542. CrossRef - Sesquiterpene lactones of Moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats
Gracianny Gomes Martins, Francislaine Aparecida dos Reis Lívero, Aline Maria Stolf, Caroline Machado Kopruszinski, Cibele Campos Cardoso, Olair Carlos Beltrame, José Ederaldo Queiroz-Telles, Regiane Lauriano Batista Strapasson, Maria Élida Alves Stefanell
Chemico-Biological Interactions.2015; 228: 46. CrossRef - Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
Hyun-Young Kim, Se-Lim Kim, Young-Ran Park, Yu-Chuan Liu, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
Intestinal Research.2015; 13(3): 233. CrossRef - Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation
THANET SOPHONNITHIPRASERT, SIRINUN NILWARANGKOON, YUKIO NAKAMURA, RAMIDA WATANAPOKASIN
International Journal of Oncology.2015; 47(6): 2188. CrossRef
- Nanomagnetic Liposome-Encapsulated Parthenolide and Indocyanine Green for Targeting and Chemo-Photothermal Antitumor Therapy
- 8,842 View
- 47 Download
- 15 Web of Science
- 11 Crossref
First
Prev
